First-Line Camrelizumab Plus Chemotherapy for Advanced Non-squamous NSCLC with Brain Metastases: Updated Data from CAP-BRAIN

被引：0
|
作者：
Hou, X. [1 ]
Zhou, C. [2 ]
Wu, G. [3 ]
Lin, W. [4 ]
Xie, Z.
Zhang, H. [2 ,5 ,6 ]
Yi, J. [7 ]
Peng, Z. [8 ]
Yin, L. [8 ]
Ma, C. [8 ]
Chen, L. [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[3] Meizhou Peoples Hosp, Huangtang Hosp, Meizhou, Peoples R China
[4] Shantou Univ, Canc Hosp, Med Coll, Shantou, Peoples R China
[5] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China
[6] Guangzhou Univ Chinese Med, Guangdong Hong Kong Macau Joint Lab Chinese Med &, Guangzhou, Peoples R China
[7] Guangzhou Red Cross Hosp, Guangzhou, Peoples R China
[8] Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-squamous non-small-cell lung cancer; Brain metastases; Immunochemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.06-04
引用
收藏
页码：S318 / S318
页数：1
相关论文
共 50 条
  • [1] First-line camrelizumab plus chemotherapy for brain metastases in NSCLC: The CTONG 2003 randomized controlled trial
    Yang, J-j.
    Li, Y.
    Yu, Q.
    Bu, Q.
    Lin, L.
    Ning, F.
    Wu, G.
    Lin, G.
    Zang, A.
    Ma, S.
    Zhou, C.
    Liu, A.
    Zhao, Y.
    Wang, C.
    Yao, Y.
    Han, G.
    Zhao, J.
    Pan, Y.
    Lv, J.
    Wu, Y-l.
    ANNALS OF ONCOLOGY, 2024, 35
  • [2] Cost-effectiveness of camrelizumab plus chemotherapy vs. chemotherapy in the first-line treatment of non-squamous NSCLC: Evidence from China
    Dai, Hongbin
    Wang, Wenyue
    Fan, Xin
    Chen, Yongfa
    FRONTIERS IN MEDICINE, 2023, 10
  • [3] Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China
    Shao, Taihang
    Ren, Yinan
    Zhao, Mingye
    Tang, Wenxi
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [4] Efficacy of Checkpoint Inhibitors in Combination with Chemotherapy for First-Line Treatment of Advanced Non-Squamous NSCLC
    Thein, K.
    Jahan, N.
    Sultan, A.
    Swarup, S.
    Tun, A.
    Yendala, R.
    Ball, S.
    Hlaing, P.
    Htut, T.
    Rehman, S.
    D'Cunha, N.
    Hardwicke, F.
    Tijani, L.
    Awasthi, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S472 - S473
  • [5] Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line Treatment for Advanced Nonsquamous NSCLC With Brain Metastases (CAP-BRAIN): A Multicenter, Open-Label, Single-Arm, Phase 2 Study
    Hou, Xue
    Zhou, Chengzhi
    Wu, Guowu
    Lin, Wen
    Xie, Zhanhong
    Zhang, Haibo
    Yi, Jiqun
    Peng, Zheng
    Yin, Lifeng
    Ma, Chi
    Chen, Likun
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) : 769 - 779
  • [6] The Cost-Effectiveness of Sugemalimab Plus Chemotherapy as First-Line Treatment for Metastatic Squamous and Non-squamous NSCLC in China
    Rihua Cheng
    Zhen Zhou
    Qiao Liu
    Advances in Therapy, 2023, 40 : 4298 - 4309
  • [7] The Cost-Effectiveness of Sugemalimab Plus Chemotherapy as First-Line Treatment for Metastatic Squamous and Non-squamous NSCLC in China
    Cheng, Rihua
    Zhou, Zhen
    Liu, Qiao
    ADVANCES IN THERAPY, 2023, 40 (10) : 4298 - 4309
  • [8] PEMBROLIZUMAB PLUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NSCLC - A NETWORK META-ANALYSIS
    Frederickson, A. M.
    Arndorfer, S.
    Lorenzi, M.
    Insinga, R.
    Chandwani, S.
    Burke, T.
    VALUE IN HEALTH, 2018, 21 : S20 - S20
  • [9] First-line treatment with gefitinib in combination with bevacizumab and chemotherapy in advanced non-squamous NSCLC with EGFR-mutation
    Xiong, Yanjuan
    Wang, Lu
    Zhang, Weihong
    Meng, Yuan
    Wang, Yang
    Shen, Meng
    Zhou, Li
    Li, Runmei
    Lv, Yingge
    Wang, Shengguang
    Ren, Xiubao
    Liu, Liang
    BMC CANCER, 2024, 24 (01)
  • [10] Italian Nivolumab Expanded Access Programme (EAP): Data from Patients with Advanced Non-Squamous NSCLC and Brain Metastases
    Crino, L.
    Bidoli, P.
    Ulivi, P.
    Minenza, E.
    Cortesi, E.
    Garassino, M.
    Cappuzzo, F.
    Grossi, F.
    Tonini, G.
    Sarobba, M. G.
    Pinotti, G.
    Numico, G.
    Samaritani, R.
    Ciuffreda, L.
    Frassoldati, A.
    Bregni, M. B.
    Santo, A.
    Piantedosi, F.
    Illiano, A.
    De Marinis, F.
    Delmonte, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1914 - S1914
12345